Download PDF

The Untied States Environmental Protection Agency (“EPA”) and Edenbridge Pharmaceuticals, LLC, (“Edenbridge”) entered into a March 3rd Expedited Settlement Agreement (“ESA”) addressing alleged violations of the New Jersey hazardous waste regulations. Docket No. RCRA-02-2022-7205.

The ESA provides that Edenbridge is the owner or operator of a facility (“Facility”) located in Parsippany, New Jersey.

EPA is stated to have conducted a review of e-manifest data of hazardous waste shipments from the Facility. Further, the federal agency is stated to have had discussions with Edenbridge regarding its findings.

EPA determined that the Facility failed to have an EPA identification number prior to transporting or offering for transport hazardous waste from the Facility. The ESA notes:

. . . during the years 2018-2020 Respondent shipped hazardous waste from its Facility using hazardous waste manifest(s) without having received an EPA identification number from the New Jersey Department of Environmental Protection in violation of 40 C.F.R. § 262.12 (1998), as incorporated by reference by N.J.A.C. 7:26G-6.1(a).

Edenbridge neither admits nor denies the allegations in the ESA

The ESA assesses a penalty of $1,250.

A copy of the ESA can be downloaded here.